Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Home

Header Top Menu

  • Careers
  • Investors
  • News
    • Press Release Archive
    • Press Statements
    • Podcasts
      • The Antigen Podcast
      • Get Science Podcast
      • Diverse Perspectives Podcast
      • menopause: unmuted
      • Hemcast
    • Contact Media Relations
    • Press Kits & Downloads
      • Company Press Kit
      • Pfizer Oncology Press Kit
      • PSA Narrative
      • RA NarRAtive
      • Rare Disease Gene Therapy Press Kit
      • ATTR-Amyloidosis Press Kit
      • UC Narrative
      • Eczema Inside Out Press Kit
  • Partners
    • Discovery to Pre-candidate
      • Focus Areas
        • Therapeutic Areas
          • Internal Medicine
          • Inflammation and Immunology
          • Oncology
          • Rare Disease
          • Vaccines
        • Therapeutic Modalities and Technology Platforms
          • Drug Safety
          • Gene Therapy
          • Target Sciences
          • Precision Medicine
          • Medicinal Sciences
            • Biologics Product & Process Development
            • Biotherapeutics Discovery
            • Medicine Design
            • Small Molecule Product & Process Development
        • Emerging Science
          • DNA Damage Response
          • Microsatellite Repeat Expansions
          • Senescence
      • Partnering Models
    • Candidate Through Commercialization
      • Focus Areas
        • Internal Medicine
        • Inflammation and Immunology
        • Oncology
        • Rare Disease
        • Vaccines
        • Hospital
    • Pfizer CentreOne
    • Pfizer Ventures
      • Our portfolio

Healthcare Professionals

  • Healthcare Professionals

Connect with Us

  • Connect with Us
    • Email
    • FAQ
    • Privacy Policy (NEW)
    • YouTube
    • Twitter
    • Facebook
    • LinkedIn
    • Instagram
  • Your Health

    • Healthy Living
      • Brain & Nervous System
      • Cardiovascular Health
      • Cold & Flu
      • Digestive Health
      • Healthier Aging
      • Living Tobacco Free
      • Men’s Health
      • Mental Health
      • Nutrition & Fitness
      • Pediatric Health
      • Respiratory Health
      • Skin Health
      • Vaccines & Prevention
      • Women’s Health

    • Disease & Condition
      • Cancer
      • Cardiovascular Diseases & Conditions
      • Diabetes & Metabolic Disorders
      • Immune System Diseases & Conditions
      • Infections & Infectious Diseases
      • Neurological Diseases & Conditions
      • Menopause
      • Rare Disease
      • Vaccine-Related Conditions
      • Skin Diseases & Conditions
      • Atopic Dermatitis
      • Cardiovascular Disease
      • Severe Hypertriglyceridemia

    • Coronavirus disease (COVID-19)

    • Managing your health
      • Caregiving
      • Evaluating Health Information
      • Tracking Your Health
      • Your Medicines
      • Health Literacy

    • Wellness
    Hot Topics

    Maintaining Emotional Well-Being During COVID-19

    Emotional Well-Being Tips for People Living with Chronic Inflammatory Conditions During COVID-19
  • Our Science

    • Driven to Discover the cure

    • Focus Areas
      • Internal Medicine
      • Inflammation & Immunology
      • Oncology
      • Rare Disease
      • Vaccines
      • Anti Infectives

    • Product Pipeline

    • Clinical Trials
      • Guide to Clinical Trials
      • Find a Trial
      • Expanded Access & Compassionate Use
      • Clinical Trials in Children
      • Partnering with Pfizer
      • Trial Data & Results
      • Research Integrity & Transparency
      • Diversity in Clinical Trials

    • R&D Platforms
      • Biosimilars
      • Gene Therapy
      • Medicinal Sciences
      • Precision Medicine
      • Maternal Immunization

    • Collaboration
      • Partner with Pfizer

    • Research sites

    • Coronavirus disease (COVID-19) Scientific Resources
    HOT TOPICS

    MRNA VS. CONVENTIONAL VACCINES

    What Makes an RNA Vaccine Different From a Conventional Vaccine?
  • Our People

    • Meet The Experts
      • Scientists
      • Internal Medicine – Metabolic Disease
      • Inflammation & Immunology
      • Oncology
      • Rare Disease
      • Vaccines
      • Medical Professionals

    • The Journey

    • Leadership
      • Executives
      • Board Members
      • Company Fact Sheet

    • Diverse Perspectives
      • Diversity & Inclusion
      • Supplier Diversity
    HOT TOPICS

    Meet our new Chief Patient Officer, Dr. Dara Richardson-Heron

    dr_richardson_300x170.jpg

    Working Together to Empower Women

    VizagWomen_300x170.jpg

    • Hot Topics
  • Our Purpose

    • Commitment to Global Health
      • Expanding Access
      • Strengthening Health Systems
      • Providing Disaster & Humanitarian Relief
      • Unleashing the Power of Our Colleagues
      • Highlighting Individual Voices

    • Protecting People and the Environment
      • Pfizer's Green Journey
      • Product Stewardship
      • EHS Governance
      • EHS Supply Chain
      • Key Performance Indicators
      • Health & Safety
      • Human Rights

    • Positions on Health Policies
      • Ready for Cures
      • How does Pfizer price medicines?
      • Value of Medicines
      • Policy Positions
      • Creating Cures Through Facility Investments

    • Transparency
      • Working with Health Care Professionals
      • Transparency in Grants
      • Code of Conduct
      • Corporate Compliance
      • Sales and Marketing Compliance

    • Independent Grants
      • Competitive Grants Program
      • Independent Medical Education
      • Investigator Sponsored Research
      • Quality Improvement
      • COVID-19 Vaccine Grants

    • Contributions & Partnerships
      • Healthcare Charitable Contributions
      • Lobbying & Political Contributions
    HOT TOPICS

    Pfizer Women’s Resource Group

    Media Name: IWD_Pull_up_Banner_300x170.jpg

    • Hot Topics
  • Our Products

    • Product listing

    • How drugs are made
      • Branded vs. Generic
      • Biologics & Biosimilars
      • Commitment to Quality

    • Distributors
      • Pfizer Distributors
      • Greenstone Distributors

    • Medicine Safety
      • Reporting Adverse Events
      • Making Good Treatment Choices
      • Partnering With Patients
      • Health Literacy
      • Medicine Safety Tips for Patients
      • Counterfeiting
      • Unused Medicines

    • Safety Data Sheets

    • Medical Information Contacts

    • Pfizer Global Supply
    HOT TOPICS

    Universal vs. Single Payer Healthcare

    Media Name: universal_healthcare300x170.jpg
  • Careers

    • Working Here
      • Mission & Purpose
      • Culture
      • Diversity & Inclusion
      • Career Growth & Colleague Development
      • Compensation & Benefits
      • Ensuring Corporate Responsibility
    • Search Jobs
    • Student & Early Career
      • Postdoctoral Program
      • US Summer Student Worker Program
      • Opportunities for Veterans
    • Pfizer365.com
    • Our Hiring & Recruiting Process
      • Frequently Asked Questions
      • Tips for Interviewing at Pfizer
    • Connect With Us
  • Investors

    • Investors Overview
      • Why Invest / Our Story
      • Prospective Investors
      • Fact Sheet
    • Events & Presentations
    • Financials
      • Quarterly Reports
      • Annual Reports
      • SEC Filings
      • Interactive Data Filings
    • Investor News
    • Stock Information
      • Historical Price Lookup
      • Investment Calculator
      • Historical Stock Chart & Data
      • Dividend & Split History
      • Stock FAQs
    • Governance
      • Board Committees and Charters
      • The Pfizer Board Policies
      • Corporate Governance FAQs
      • Contact Our Directors
    • Shareholder Services
      • Stock FAQs
      • Advisory Information
      • Cost Basis Calculator
  • News

    • Contact Media Relations
    • Podcasts
    • Press Kits & Downloads
    • Press Release Archive
    • Press Statements
  • Partners
  • Footer links

    • Footer Aside Section1
      • CAREER-SEEKERS
      • INVESTORS
      • News & Media
      • Partners
    • Footer Aside Section 2
      • Healthcare Professionals
      • Business To Business
      • Change Region
      • Sitemap
    • Footer Aside Section3
      • Twitter
      • Facebook
      • Linkedin
      • Instagram
      • Youtube
    • Footer Aside Section4
      • Contact Us
      • Terms of Use
      • Privacy Policy

Pfizer Pearl River site looking to add difference makers

Pfizer Pearl River site looking to add difference makers
OUR SCIENCE/ Pfizer Pearl River site looking to add difference makers
May 9, 2019

Pfizer is actively looking to hire dozens of people in Pearl River to continue the research and development site's legacy of innovation. Professionals who aspire to make a difference in human health around the world by applying their knowledge and skills are welcomed to explore the career opportunities available at the site today.

Many of the Pearl River-based positions listed in the Pfizer careers website are for scientists in the site's Vaccine Research & Development group, but there are also other opportunities. Pfizer Pearl River is a fully integrated research and development center. Developing a new vaccine or cancer therapy requires several thousand colleagues in different roles working together. Career opportunities for qualified individuals are available across the entire research and development spectrum.

Opportunities currently exist for discovery scientists, bacteriologists, virologists, bio-process development scientists, assay developers, robotics programmers, systems programmers, clinical laboratory scientists, operational staff and clinicians. A full list of opportunities can be found through Pfizer.com.

Pfizer is actively looking to hire dozens of people in Pearl River to continue the site's legacy of innovation. The Pearl River location, which employs over 750 people and is one of Pfizer's nine major R&D sites and a manufacturer targeted cancer therapies, is hoping to continue attracting scientists from around the area and elsewhere in the world to do their best work.

What's happening at the Pearl River site today

The Pearl River location, currently employs over 750 people and is one of Pfizer's nine major R&D sites and a manufacturer of targeted cancer therapies. Among the long-standing allures of the site are its Lower Hudson Valley location and proximity to New York City and New Jersey.

Recently, Pfizer announced the initiation of Phase 3 clinical testing with groups of adults for a next generation vaccine to protect against additional disease-causing serotypes of pneumococcal bacteria. Another innovative Pearl River Vaccine R&D project is aimed at protecting against infections caused by Clostridium difficile.

Colleagues in Pearl River are also focused on researching and developing vaccines that could provide protection against neonatal infections such as those caused by Group B streptococcus, and respiratory syncytial virus (RSV).

“RSV, for example, is responsible for nearly 120,000 infant deaths annually worldwide and is the leading cause of infant hospitalization in the developed world,” said Kena Swanson, director, Viral Vaccines, at Pfizer's Pearl River site and Rockland County resident. The Pearl River site is pioneering maternal vaccines, which have the potential of passing on a level of protection to infants prior to birth with the goal of significantly impacting the health of millions of babies.

Researchers in Pearl River are also part of a broader Pfizer effort to develop oncology treatments that are as diverse as cancer itself, with a sharp focus on the most disruptive advances in science and guided by the urgency to help patients receive the next wave of life-changing cancer medicines.

“Together with our Pearl River colleagues, I am thrilled to be able to continue the strong and lasting scientific legacy of the Pearl River site,” said Kathrin Jansen, senior vice president and head of Vaccine R&D. “Over the last two decades we have been building on this legacy through the development of a robust portfolio of life-saving vaccines and cancer therapies.”

A history of life-changing impact

The research and development work being done at the Pearl River site today is continuing a century of innovation that has had life-changing impact around the world, from immunizing children against deadly infectious diseases to developing potential breakthrough therapies for leukemia. Its legacy of innovation dates back to 1907, when Dr. Ernst Lederle established the Pearl River site to produce antiserum to treat children with diphtheria in New York City. Since then, the Pearl River site has developed vaccines to prevent diseases like smallpox and polio.

Centrum®, the world's top-selling multivitamin, was developed and first manufactured in Pearl River in 1978. In 1988, a mitoxantrone-product developed in Pearl River was introduced. A very potent new class of anti-cancer agent, it proved highly effective against breast cancer, several blood cancers, as well as non-remitting multiple sclerosis.

Among the diverse group of colleagues are those whose tenure with the company dates back to the 1980s. They've seen important evolution as well as continued and exemplary innovation at the site since that time.

“I appreciate the incredible talent and collegiality of everyone who works here,” stated Ed Bennett, currently director of Global Operations, who began working at the site over 30 years go. “There are subject matter experts everywhere. We have best-in-class people who are always happy to help. I realize not every place is like here. It's special because of the diversity of people, thought and expertise. It makes working here exciting.”

Supporting the community

Pfizer colleagues are also continuing the Pearl River site's tradition of giving back to the community. Beyond their day jobs, many have generously given their time to support local charitable organizations for which they are passionate. In recent years, Pearl River colleagues have continually donated time and money to the People to People food bank in Nanuet and United Way of Rockland County. Dozens participate in United Way's Day of Caring events, and many more contribute food, clothing and school supplies to People to People.

The Pearl River site has also supported public education and colleges with donations of laboratory equipment, funding for science, technology, engineering, and mathematics programs and scholarships, and hosted students on-site.

To learn more about open positions at the Pfizer Pearl River site, go to: https://pfizer.wd1.myworkdayjobs.com/PfizerCareers and under “Search for Jobs,” type in “Pearl River.” Prospective candidates can also check the “United States – New York – Pearl River” box under “Current Search” and “All Locations.”

pearl_river_site1.jpg
Pfizer is actively looking to hire dozens of people in Pearl River to continue the site's legacy of innovation. The Pearl River location, which employs over 750 people and is one of Pfizer's nine major R&D sites and a manufacturer targeted cancer therapies, is hoping to continue attracting scientists from around the area and elsewhere in the world to do their best work.

pearl_river_site2.jpg
(above) Colleague working with robotic sample-handling system in Pfizer Pearl River Vaccine R&D laboratory

pearl_river_site3.jpg
(above) Colleague at fermentation tanks at Pfizer Pearl River Vaccine R&D Early Bioprocess Development Laboratory

Show
Hide

Footer menu

  • Your Health
    • Healthy Living
    • Disease Conditions
    • Manage Your Health
  • Our Science
    • Therapeutic Areas
    • Product Pipeline
    • Clinical Trials
    • R&D Platforms
    • Collaboration
    • Research SItes
  • Our People
    • Meet the Experts
    • The Journey
    • Leadership
    • Diverse Perspectives
  • Our Purpose
    • Commitment To Global Health
    • Positions on Health Policies
    • Transparency
    • Contributions & Partnerships
  • Our Products
    • Product Listing
    • How Drugs are Made
    • Distributors
    • Global Product Information Contacts

Footer aside

  • Footer Aside Section1
    • CAREER-SEEKERS
    • INVESTORS
    • News & Media
    • Partners
  • Footer Aside Section 2
    • Healthcare Professionals
    • Business To Business
    • Change Region
    • Sitemap
  • Footer Aside Section3
    • Twitter
    • Facebook
    • Linkedin
    • Instagram
    • Youtube
  • Footer Aside Section4
    • Contact Us
    • Terms of Use
    • Privacy Policy
Pfizer Logo Footer

Copyright © 2002-2021 Pfizer Inc. All rights reserved. This information—including product information—is intended only for residents of the United States.
The products discussed herein may have different labeling in different countries.